A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis	Nutritional and Metabolic Diseases, amyloidosis, metabolic disease, proteostasis deficiencies	Active, not recruiting	Phase 2	2026-09-25		NCT05250973

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Janssen Research & Development, LLC	188

46 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Alexandra General Hospital of Athens	Athens	Greece	13
Barbara Ann Karmanos Cancer Institute	Detroit	United States	44
Boston University Medical Center	Boston	United States	16
Centre Hospitalier Lyon-Sud	Pierre-Bénite	France	8
Charite Campus Benjamin Franklin	Berlin	Germany	6
CHU de Limoges	Limoges	France	24
Chu de Poitiers	Poitiers	France	30
CHU Rangueil	Toulouse	France	2
City of Hope	Duarte	United States	238
Clinica Univ. de Navarra	Pamplona	Spain	42
Clinica Univ. de Navarra 1	Madrid	Spain	2
Cross Cancer Institute	Edmonton	Canada	146
DIPARTIMENTO DI BIOTECNOLOGIE CELLULARI ED EMATOLOGIA - UNIVERSITà ''LA SAPIENZA''	Roma	Italy	2
First affiliated Hospital of Zhejiang University	Hangzhou	China	5
Fondazione IRCCS Policlinico San Matteo	Pavia	Italy	75
Hosp Clinic de Barcelona	Barcelona	Spain	37
Hosp Clinico Univ de Salamanca	Salamanca	Spain	34
Hosp Univ Vall D Hebron	Barcelona	Spain	46
Hosp. Univ. Germans Trias I Pujol	Badalona	Spain	28
Hospital Maastricht University Medical Center	Maastricht	Netherlands	1
Leicester Royal Infirmary - Haematology	Leicester	United Kingdom	2
Levine Cancer Institute	Charlotte	United States	110
Memorial Sloan Kettering	New York	United States	27
Moffitt Cancer Center	Tampa	United States	523
Ohio Health Research Institute	Columbus	United States	18

Clinical trials